Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Colonization factor antigen II (CFA/II) fimbriae are surface-exposed, proteinaceous appendages produced by certain strains of enterotoxigenic Escherichia coli (ETEC). These fimbriae mediate bacterial adhesion to host intestinal epithelial cells, essential for colonization and diarrheal disease. Consisting of polymerized major subunits and minor adhesive tip subunits, they are highly immunogenic and serve as a target for anti-adhesion therapies and vaccine development, particularly focusing on the minor adhesive subunits.
Anti-fimbrial antibodies can inhibit adhesion by compromising the mechanical resilience of the fimbriae, preventing proper host cell attachment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Colonization Factor Antigen II Fimbriae (CFA/II).